Related Experiment Videos
Immune dysregulation in atopic eczema
J D Bos1, E A Wierenga, J H Sillevis Smitt
1Department of Dermatology, University of Amsterdam, Academisch Medisch Centrum, The Netherlands.
Archives of Dermatology
|November 1, 1992
Summary
Atopic eczema involves a self-perpetuating skin immune response to allergens, driven by abnormal T-cell cytokine production and immunoglobulin E (IgE) regulation. This highlights potential new therapeutic targets for atopic dermatitis.
Area of Science:
- Immunology
- Dermatology
- Allergy
Background:
- Atopic eczema (AE) pathogenesis involves complex immune dysregulation, not solely systemic or cutaneous cell-mediated immunity deficits.
- Evidence suggests activated T cells and dendritic cells in affected skin, alongside vigorous peripheral T-cell activation in atopic dermatitis.
Purpose of the Study:
- To summarize current knowledge on atopic eczema immunopathogenesis, incorporating recent discoveries.
- To investigate the role of T cells, IgE regulation, and cytokine production in AE.
Main Methods:
- Analysis of IgE interactions with Langerhans cells in skin.
- Preparation and characterization of T-cell clones from atopic skin and peripheral blood.
- Determination of T-cell specificity and cytokine production profiles.
Main Results:
- Involved skin shows in situ production of interleukin 4 (IL-4) and interleukin 5 (IL-5) in response to environmental antigens.
- Abnormal regulation of IgE synthesis involves preferential expansion of IL-4 and IL-5 producing T cells.
- Activated T cells and dendritic cells are present in lesional skin.
Conclusions:
- Atopic eczema pathogenesis involves a distorted, cytokine-mediated, self-perpetuating immune response to environmental allergens.
- Abnormal T-cell cytokine secretion patterns are central to atopy-related disorders.
- These findings may inform the development of novel therapies for atopic eczema.